Skip to content
Brand AI

赛恺泽

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    CARsgen Therapeutics releases 2026 interim results

    CARsgen Therapeutics (2171.HK) released its 2026 interim results, reporting revenue of approximately RMB 62 million for the six months ended June 30, 2026, mainly from zevor-cel (赛恺泽), gross profit of approximately RMB 42 million, and cash and cash equivalents of approximately RMB 1.4 billion as of June 30, 2026.

    Source